2158362-38-8
Chemical Structure
Neihulizumab
Synonym(s): ALTB-168; Anti-PSGL1/CD162 Reference Antibody (neihulizumab); AbGn-168
- CAS No.: 2158362-38-8
- Formula:N/A
- Molecular Weight:(145.72 kDa)
IUPAC Name: N-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy-2,3,5,6-d4)propan-1-amine oxalate
SMILES: [Neihulizumab]
Biological Activity: Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Neihulizumab | 98.97% | Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
